Aspira Women's Health Inc.

Diagnostics company · Austin, Texas, United States · OTC: AWHL

Aspira Women's Health Inc. is a diagnostics company headquartered in Austin, Texas, United States. Its shares trade on OTC under the ticker AWHL. The US FDA lists 1 medical device site registered to the company, with devices in obstetrics and gynecology. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Aspira Women's Health at a glance

Typediagnostics company
HeadquartersAustin, Texas, United States
Stock listingOTC: AWHL
SEC industryIn Vitro & In Vivo Diagnostic Substances
FDA-registered sites1
SEC CIK926617

What does Aspira Women's Health do?

Medical specialties of its FDA-listed devices

Obstetrics and Gynecology

Device types listed with the FDA

Ovarian adnexal mass assessment score test system

Private fundraising reported to the SEC

8 Form D notices; the most recent reported $1.5 million sold (2026).

Where is Aspira Women's Health located?

Headquarters: Austin, Texas, United States

  • Austin, TexasAspira Women's Health, Inc. · FDA device site

Frequently asked questions about Aspira Women's Health

Where is Aspira Women's Health headquartered?

Aspira Women's Health Inc. is headquartered in Austin, Texas, United States.

What does Aspira Women's Health do?

Aspira Women's Health Inc. is a diagnostics company. Its FDA-listed medical devices fall under obstetrics and gynecology. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.

Is Aspira Women's Health a public company?

Yes. Aspira Women's Health Inc. trades on OTC under the ticker AWHL.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.